Preventing infections in ICU patients on ventilators
Part of Infections clinical trials.
This trial tests an experimental drug called Fluorothiazinone to prevent serious bacterial infections in ICU patients who are on a breathing machine (ventilator) or likely to need one soon. It includes patients with COVID-19 pneumonia, stroke, or heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and in the Intensive Care Unit (ICU).
- You have either COVID-19 with severe pneumonia, a recent stroke, or acute heart failure.
- If you are on a breathing machine (ventilator), it has been for less than 12 hours.
- You are expected to need a ventilator within the next 3 days.
- You and your partner (if applicable) agree to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving inhaled antibiotics based on a patient's own airway bacteria can prevent ventilator-associated pneumonia (a lung infection from the breathing tube) in intensive care patients. It may help reduce infections in people who need a breathing tube for more than three days.
This trial tests a drug called AVM0703 to see if it can help people with severe lung damage caused by COVID-19 or influenza. It focuses on patients who need a breathing machine or ECMO because their lungs are failing.
This trial tests whether breathing in special viruses (called phages) that attack the Pseudomonas bacteria can help clear a serious lung infection in patients on ventilators. The treatment is added to standard antibiotics and may help fight the infection better.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
This study tests two different mouth-care solutions for patients on breathing machines, to see if they can prevent pneumonia and improve mouth health in intensive care.
This trial tests whether inhaling an antibiotic called tobramycin can prevent a serious lung infection in patients who need a breathing tube. It may help people at higher risk for difficult-to-treat infections.
Hear when a new Gram-Negative Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.